首页> 外文期刊>Archives of rheumatology. >Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study
【24h】

Effectiveness of Ultrasound Therapy on Myofascial Pain Syndrome of the Upper Trapezius: Randomized, Single-Blind, Placebo-Controlled Study

机译:超声疗法对斜方肌肌筋膜疼痛综合征的有效性:随机,单盲,安慰剂对照研究

获取原文
           

摘要

Objectives: This study aims to evaluate the effectiveness of conventional ultrasound (US) therapy in the treatment of myofascial pain syndrome. Patients and methods: Fifty-four patients (23 males, 31 females; mean age 29.8±5.2 years; range, 22 to 46 years) with myofascial pain syndrome were included in this prospective, randomized, single-blind, placebo-controlled study. Patients were randomized into two groups by computerized method as US group (n=27) and placebo group (n=27). Ten sessions of US were applied to the US group and 10 sessions of placebo US were applied to the placebo group. Treatment effectiveness was evaluated with Visual Analog Scale (VAS), algometer, palpable muscle spasm degree (PMSD), and Beck Depression Inventory (BDI) before and after treatment. Results: Pain values after treatment in both groups decreased significantly (p0.05) compared to before treatment. In the US group, the decrease in VAS and palpable muscle degree before and after treatment was significantly higher (p0.05) than in the placebo group. In the US group, the decrease in PMSD after treatment was significantly higher than the placebo group (p0.05). The amount of decrease in BDI score before and after treatment in the US group did not differ significantly from the placebo group (p0.05). Conclusion: Our findings show that conventional US therapy is effective in the treatment of myofascial pain syndrome.
机译:目的:本研究旨在评估常规超声(US)疗法在肌筋膜疼痛综合征治疗中的有效性。患者和方法:这项前瞻性,随机,单盲,安慰剂对照研究纳入了54例肌筋膜疼痛综合征患者(男23例,女31例;平均年龄29.8±5.2岁;范围22至46岁)。通过计算机方法将患者随机分为两组,分别为US组(n = 27)和安慰剂组(n = 27)。在美国组中应用了10届美国会议,在安慰剂组中应用了10届美国安慰剂会议。治疗前后用视觉模拟量表(VAS),血压计,可触知的肌肉痉挛程度(PMSD)和贝克抑郁量表(BDI)评估治疗效果。结果:与治疗前相比,两组治疗后疼痛值均显着降低(p <0.05)。在美国组中,治疗前后VAS和可触及肌肉程度的降低明显高于安慰剂组(p <0.05)。在美国组中,治疗后PMSD的降低显着高于安慰剂组(p <0.05)。美国组治疗前后BDI评分降低的幅度与安慰剂组无显着差异(p> 0.05)。结论:我们的发现表明,常规的美国疗法可有效治疗肌筋膜疼痛综合征。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号